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Abstract
In order to attenuate or to prevent chromate-induced human erythrocytes injury, the influence of vitamin E,
vitamin C, salicylate, deferoxamine, and N-ethylmaleimide on chromate-induced human erythrocytes haemoglobin
oxidation and peroxidation were investigated. It was observed that pretreatment of human erythrocytes with vitamin
E (20 mM), vitamin C (1 mM), salicylate (3 mM), and deferoxamine (4 mM) significantly increased (P0.0001)
chromate-induced human erythrocytes haemoglobin oxidation in a time dependent manner, while it was significantly
decreased (P0.0001) by pretreatment with N-ethylmaleimide (1 mM). In contrast, pretreatment of human
erythrocytes with deferoxamine (4 mM) immediately inhibited (P0.0001) chromate-induced human erythrocytes
peroxidation, while it was significantly increased (P0.0001) by pretreatment with N-ethylmaleimide (1 mM) during
the first 4 h of cells exposition to chromate. For time periods superior to 6 h pretreatment with N-ethylmaleimide (1
mM) significantly decreased (P0.0001) chromate-induced human erythrocytes peroxidation. It was concluded that
care must be taken as these drugs are used to prevent against toxicity induced by chromium(VI) compounds. © 2000
Elsevier Science Ireland Ltd. All rights reserved.
Keywords: Antioxidants; Chromate; Cytotoxicity; Haemoglobin oxidation; Human erythrocytes; Oxidative stress
www.elsevier.com:locate:toxlet
1. Introduction
Chromium (VI) is a widespread toxic metal ion
present in industrial effluents and wastes. The
toxic and carcinogenic effects of chromate have
been attributed to chromium(VI) compounds,
which readily cross the cell membranes and enter
the cells, being reduced through reactive interme-
diates such as chromium(V) and chromium(IV) to
the more stable chromium(III) by intracellular
reductants such as ascorbate, glutathione, and
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NADPH-dependent flavoenzymes. This reduction
process also causes the generation of reactive
oxygen species (ROS) via Fenton or Haber–Weiss
type reactions. Because ROS can produce a num-
ber of toxic reactions including DNA damage and
lipid peroxidation, the toxic and carcinogenic ef-
fects of chromium(VI) may be partially associated
with the production ROS (Shi et al., 1999). There-
fore, therapeutic agents that enhance intra-and
extracellular antioxidant levels and block chromi-
um(VI)-mediated generation of ROS may prevent
or attenuate chromium(VI)-induced toxicity and
carcinogenesis (Shi et al., 1999).
The role of physiological antioxidants, namely
vitamin E and vitamin C, as well as the role of the
membrane-permeable metal-chelating agent defer-
oxamine in chromium(VI)-induced cellular injury,
including cytotoxicity, and lipid peroxidation has
been studied in mammalian cells and experimental
animals (Sugiyama, 1992; Susa et al., 1996, 1997).
It has been shown that pretreatment of cultured
Chinese hamster V-79 cells with vitamin E pro-
tected cells from chromate-induced cytotoxicity
(Sugiyama et al., 1989). By contrast, treatment of
these cells with vitamin C enhanced chromate-in-
duced cytotoxicity (Sugiyama et al., 1991). Al-
though pretreatment of isolated rat hepatocytes
with vitamin E or vitamin C protected the cells
from chromium(VI)-induced lipid peroxidation
(Ueno et al., 1989), vitamin E had no effect on
chromate-induced cytotoxicity (Ueno et al., 1989).
Moreover, pretreatment of primary cultures of rat
hepatocytes with vitamin E (Susa et al., 1996) or
deferoxamine (Susa et al., 1997) protected cells
from both chromate-induced cytotoxicity and
lipid peroxidation. In animals studies, it has been
shown that dietary pretreatment of rats or guinea
pigs with vitamin E (Chorvatovicova´ et al., 1991)
or vitamin C (Ginter et al., 1989; Chorvatovicova´
et al., 1991) protected bone marrow cells from
chromium(VI)-induced cytoxicity. However, both
vitamin E and vitamin C dietary intake had no
effect on liver peroxidation of chromium(VI)-in-
toxicated rats (Ginter et al., 1989; Chorvatovicova´
et al., 1991). Other studies, reported that vitamin
C protected the liver and the kidney of mice
treated with chromium(VI) from chromate-in-
duced peroxidation (Susa et al., 1989). It has also
been shown that the toxic effect of chromium(VI)
on liver microsomes was pronounced in guinea
pigs with marginal vitamin C deficiency (Ginter et
al., 1989).
Previous studies performed in our laboratory
showed that chromate-induced haemoglobin oxi-
dation and membrane peroxidation in human ery-
throcytes (Alpoim et al., 1995; Fernandes et al.,
1999). It also promoted oxidation of GSH, inhibi-
tion of glutathione reductase and methaemo-
globin reductase, and the echinocytic shape trans-
formation of erythrocytes. However, chromate
was without effect on the activities of catalase,
gluthatione peroxidase, and superoxide dismutase,
as well as on the osmotic fragility of the cells
(Fernandes et al., 1999). Based on these findings it
was suggested that chromate may be cytotoxic to
human erythrocytes. It should be taken into ac-
count that in human erythrocytes the intracellular
redox balance glutathione reduced:glutathione ox-
idized, haemoglobin:methaemoglobin ratio, and
the cell shape, which are crucial for cell functions
and survival, are irreversibly disrupted (Fernandes
et al., 1999).
In order to attenuate or to prevent chromate-
induced human erythrocytes injury, in the present
study we tested the influence of antioxidants,
namely vitamin E, vitamin C, and salicylate, a
phenolic compound with ability to scavenge hy-
droxyl radicals (Gassen and Youdim, 1999), as
well as the influence of the membrane-permeable
metal-chelating agent deferoxamine (Romero et
al., 1996), and that of the thiol groups blocker
N-ethylmaleimide (Snyder et al., 1988; Sullivan et
al., 1992) on the chromate-induced human ery-
throcytes haemoglobin oxidation and peroxida-
tion. N-ethylmaleimide was used because blocking
thiol groups may decrease chromium(VI)-reduc-
tion by intracellular reductants and, consequently,
the cytotoxic effects of chromate.
2. Materials and methods
2.1. Chemicals
All chemicals were obtained from Sigma Chem-
ical Company (St Louis, MO, USA) except
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sodium dichromate and deferoxamine, which were
purchased from Aldrich (Milwaukee, WI, USA)
and Ciba–Geigy (Basel, Switzerland), respec-
tively.
2.2. Preparation of human erythrocyte suspensions
Venous blood (20 ml) was obtained from
healthy volunteers into blood collection tubes
containing acid citrate dextrose as anticoagulant.
The blood was centrifuged at 600g in a bench
centrifuge (Sigma-302) for 5 min at 4°C. The
plasma and buffy coat were removed and the
erythrocytes were washed three times with 20 ml
of 0.9% NaCl solution. The erythrocytes were
subsquently diluted to 30 ml with Hepes buffer
(10 mM Hepes, 10 mM glucose and 140 mM
NaCl, pH 7.4), and enumerated with a Cell–Dyn
1600. The number of erythrocytes in the suspen-
sion was adjusted to a concentration of approxi-
mately 3 000 000 erythrocytes:ml with Hepes
buffer and the haemoglobin content measured by
using the Drabkin’s method (Drabkin and Austin,
1932).
2.3. Measurement of human erythrocytes
haemoglobin oxidation
The human erythrocytes haemoglobin oxida-
tion was studied in cells either untreated and
pretreated with a-tocopherol succinate (vitamin
E), vitamin C, sodium salicylate (salicylate), or
deferoxamine (DFO) as follows: aliquots of hu-
man erythrocyte suspensions containing 2.5 mg:
dm3 of haemoglobin in Hepes buffer were
incubated with vitamin E succinate (20 mM), vita-
min C (1 mM), sodium salicylate (3 mM) or DFO
(4 mM) at 30°C for 2 h in a final volume of 2 ml.
At the end of the incubation time 4 mM dichro-
mate were added, and the levels of haemoglobin
oxidation were measured according to the method
of Martinek (1965), at several time periods along
1 h of exposition of the cells to dichromate.
The human erythrocytes haemoglobin oxida-
tion was also studied in N-ethylmaleimide (NEM)
pretreated human erythrocytes and untreated
cells. In this case, aliquots of human erythrocyte
suspensions containing 2.5 mg:dm3 of haemo-
globin in Hepes buffer were incubated with 1 mM
NEM in 0.9% NaCl at 25°C for 30 min, in a final
volume of 20 ml. At the end of the incubation
time, the cells were washed five times with 0.9%
NaCl, adjusted to a concentration of approxi-
mately 3 000 000 erythrocytes:ml by dilution with
Hepes buffer, and the haemoglobin content mea-
sured by the method reported above.
Controls with and without dichromate, sodium
salicylate, DFO, vitamin E, vitamin C, were car-
ried out simultaneously. Ethanol (1%) was used as
vitamin E solvent. Thus, in the experiments with
vitamin E, the controls were performed in the
presence of ethanol (1%). The results were ex-
pressed as percentage (%) of haemoglobin
oxidation.
2.4. Measurement of human erythrocytes
peroxidation
The measurement of human erythrocytes perox-
idation was performed in cells either untreated or
treated with DFO and NEM as described above
for the measurement of human erythrocytes
haemoglobin oxidation. The assays were per-
formed using 10 ml of human erythrocyte suspen-
sions in Hepes buffer (3106 cells:ml) incubated
at 30°C. The reactions were initiated by the addi-
tion of 8 mM dichromate and the peroxidation
levels were measured at several time periods along
8 h of exposition of the cells to dichromate. The
levels of human erythrocytes peroxidation were
measured using 0.5 ml aliquots of human erythro-
cyte suspensions. Briefly, 0.5 ml aliquots of hu-
man erythrocyte suspensions were cooled down to
0°C and 0.5 ml of 20% tricloroacetic acid (TCA)
was added. The samples were vortexed, cen-
trifuged at 600g in a bench centrifuge (Sigma-
302) for 3 min at 4°C and the supernatant
carefully removed. Two ml of 0.75% of thiobarbi-
turic acid (TBA) in 0.1 M HCl were then added to
the supernatant and the mixture heated at 90°C
for 15 min, recooled in ice for 10 min, centrifuged
again for 15 min at 850g and the supernatant
carefully removed. The peroxidation levels were
evaluated by measuring thiobarbituric acid-reac-
tive substances (TBARS), as described by Ernster
and Nordenbrand (1967). The results were ex-
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pressed as nmol of malonaldehyde per million of
cells (nmol MDA:106 cells).
2.5. Statistical analysis
All the experiments were performed using at
least three different blood samples and conducted
in duplicate. The values are expressed as means9
SD. Means were compared using ANOVA. Multi-
ple comparisons with the PLSD Fisher and
F-Scheffe-test were performed when ANOVA
showed significant results. Statistical significance
was set at PB0.05.
3. Results
3.1. Time dependent effects of 6itamin E, 6itamin
C, salicylate, deferoxamine, and N-ethylmaleimide
on dichromate-induced human erythrocytes
haemoglobin oxidation
The time dependent effects of vitamin E (20
mM), vitamin C (1 mM), salicylate (3 mM), DFO
(4 mM), and NEM (1 mM), on 4 mM dichro-
mate-induced human erythrocytes haemoglobin
oxidation are shown in Fig. 1. It was observed
that pretreatment of human erythrocytes with vi-
tamin E, vitamin C, salicylate, and DFO signifi-
cantly increases (P0.0001) dichromate-induced
human eryhrocytes haemoglobin oxidation in a
time dependent manner, while it was significantly
decreased by pretreatment with N-ethylmaleimide
(P0.0001). Vitamin E, vitamin C, salicylate and
DFO alone have no effect on human erythrocytes
haemoglobin oxidation.
3.2. Time dependent effects of deferoxamine and
N-ethylmaleimide on dichromate-induced human
erythrocytes peroxidation
The time dependent effects of DFO (4 mM)
and NEM (1 mM) on 8 mM dichromate-induced
human erythrocytes peroxidation are shown in
Fig. 2. It can be observed that pretreatment of
human erythrocytes with DFO immediately in-
hibits (P0.0001) dichromate-induced human
erythrocytes peroxidation. In turn, pretreatment
of human erythrocytes with NEM significantly
increases (P0.0001) dichromate-induced human
erythrocytes peroxidation during the first 4 h of
Fig. 1. Time dependent effects of vitamin E, vitamin C,
salicylate, DFO and NEM on 4 mM dichromate-induced
human erythrocytes haemoglobin oxidation. Results corre-
spond to means9SD of at least three samples carried out in
duplicate.
Fig. 2. Time dependent effects of DFO and NEM on 8 mM
dichromate-induced human erythrocytes peroxidation. Results
correspond to means9SD of at least three samples carried
out in duplicate.
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erythrocytes exposition to dichromate, decreasing
it significantly (P0.0001) for exposition times
above 6 h. Deferoxamine and NEM alone have
no effect on human erythrocytes peroxidation.
It is important to remark the following: firstly,
under the assay conditions (pH\7 and dichro-
mate concentration below 101 M), dichromate
depolymerise giving rise to chromate ions (Mahan
and Myers, 1987), which readily cross the erythro-
cyte membranes and enters the cells (Connett and
Wetterhahn, 1983). Thus, when we say ‘exposition
of the cells to 4 mM and 8 mM dichromate’ it
means that the cells were exposed to 8 mM and 16
mM chromate, respectively. In this study both the
terms ‘dichromate’ and ‘chromate’ were used. The
term ‘dichromate’ refers to sodium dichromate,
and it appears in the Section 2, Section 3 and
Figs. 1 and 2. The term ‘chromate’ referes to
chromate ions, and it appears in the Abstract,
Section 1 and Section 4; secondly, human erythro-
cytes haemoglobin oxidation and peroxidation
were studied using 4 mM and 8 mM dichromate,
respectively. Because the levels of peroxidation
induced by 4 mM dichromate in human erythro-
cytes were very low and accurate values difficult
to measure (results not shown), in the present
investigation we used 8 mM dichromate instead of
4 mM to study human erythrocytes peroxidation;
thirdly, the concentrations of salicylate (3 mM)
and DFO (4 mM) were the lowest that, under the
assay conditions, increased significantly dichro-
mate-induced human erythrocytes haemoglobin
oxidation (results not shown); finally, from the
drugs tested, DFO and NEM were those with the
major promoting and inhibitory effects, respec-
tively, on dichromate-induced human erythrocytes
haemoglobin oxidation. Therefore, they were se-
lected to study their effects on dichromate-in-
duced human erythrocytes peroxidation.
4. Discussion
The aim of this study was to investigate if
pretreatment of human erythrocytes with vitamin
E, vitamin C, salicylate, DFO and NEM is able to
attenuate or to prevent chromate-induced human
erythrocytes injury, namely cytotoxicity evaluated
by haemoglobin oxidation, and peroxidation eval-
uated by TBARS.
The present results demonstrate that pretreat-
ment of human erythrocytes with vitamin E (20
mM), vitamin C (1 mM), salicylate (3 mM) and
DFO (4 mM) potentiate chromate-induced hu-
man erythrocytes cytotocicity in a time dependent
manner, while it is attenuated by NEM (1 mM).
In contrast, pretreatment of human erythrocytes
with DFO (4 mM) immediately prevented chro-
mate-induced human erythrocytes peroxidation,
while it was potentiated by pretreatment with
NEM (1 mM) during the first 4 h of exposition of
human erythrocytes to chromate. For exposition
times superior to 6 h pretreatment of the cells
with NEM (1 mM) attenuated chromate-induced
peroxidation.
In our recent study, it was suggested that dur-
ing the intracellular human erythrocytes chromi-
um(VI) reduction to chromium(V) intermediates,
by glutathione, glutathione reductase and
NADH-methaemoglobin reductase, ROS are pro-
duced via the Haber–Weiss cycle or through a
Fenton-like reaction (Fernandes, et al., 1999). It
was also suggested that chromate-induced human
erythrocytes haemoglobin oxidation is due to the
electron transfers between the haemoglobin-Fe2
and chromium(V) intermediates, and that chro-
mate-induced haemoglobin oxidation protects the
cells against chromate-induced peroxidation (Fer-
nandes et al., 1999). The oxidation of haemo-
globin (Alpoim et al., 1995), which is the main
protein inside human erythrocytes will readily re-
duce chromium(VI) and chromium(V) to the sta-
ble oxidation state chromium(III), which remain
bound to the oxidized protein (Connett and Wet-
terhahn, 1983) not allowing ROS generation.
The finding showing that pretreamentss of hu-
man erythrocytes with vitamin E, vitamin C, sali-
cylate and DFO potentiates chromate-induced
cytotoxicity, together with that showing that pre-
treatment of the cells with DFO prevents chro-
mate-induced peroxidation, indicates that these
drugs potentiate the electron transfers between the
haemoglobin-Fe2 and chromium(V) intermedi-
ates, decreasing chromium(V) intermediates -me-
diated generation of ROS via the Haber–Weiss
cycle or through a Fenton-like reaction. In fact, it
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has been reported that cellular pretreatment with
vitamin E (Sugiyama et al., 1989) or vitamin C
(Sugiyama, 1991) decreases the levels of chromi-
um(V) intermediates within cells treated with
chromium(VI), while DFO supresses the levels of
chromium(V) intermediates formed during reduc-
tion of chromium(VI), resulting in a decrease of
chromium(V) intermediates -mediated hydroxyl
radical formation (Shi and Dalal, 1992; Shi et al.,
1992). Although there is no information concern-
ing the effect of salicylate on chromium(VI)-re-
duction salicylate, like vitamin E, vitamin C, and
deferoxamine (Morehouse et al., 1987; Gassen
and Youdim, 1999; May, 1999), has an hydroxyl
group with abilities to chelate chromium and to
participate in oxidation-reduction reactions
(Carey, 1996). Therefore, it is possible that salicy-
late supresses the levels of chromium(V) interme-
diates formed during reduction of chromium(VI)
by a process similar to those described for vitamin
E, vitamin C and DFO.
The findings showing that pretreatment of hu-
man erythrocytes with NEM attenuates chromate-
induced cytotoxicity and potentiates chromate-
induced peroxidation during the first 4 h of cells
exposition to chromate, indicates that NEM de-
creases the electron transfers between the
haemoglobin-Fe2 and chromium(V) intermedi-
ates increasing chromium(V) intermediates -medi-
ated generation of ROS via the Haber–Weiss
cycle or through a Fenton-like reaction in cells
exposed to chromate during this time period.
However, in NEM pretreated cells exposed to
chromate for time periods superior to 6 h chro-
mate-induced peroxidation was attenuated. This
may be achieved by decreasing the content of
chromium(V) intermediates in human erythro-
cytes as a consequence of lowering chromium(VI)-
reduction by intracellular thiol-reductants.
The protective or stimulative mechanisms of
vitamin E, vitamin C, salicylate, DFO and NEM
to chromate-induced human erythrocytes cytotox-
icity and peroxidation are not yet known. In spite
of this, it is possible to speculate that these mech-
anisms rely on drug abilities to change either the
reduction potential of chromium(V) intermedi-
ates, affecting the electron transfers between the
haemoglobin-Fe2 and chromium(V) intermedi-
ates, or the generation of chromium(V) intermedi-
ates during chromium(VI)-reduction by intra-
cellular reductants, affecting the levels of intracel-
lular thiol-antioxidants such as glutathione and
glutathione-reductase, as well as NADH-
maethaemoglobin reductase activity, which have
been shown to be suppressed in human erythro-
cytes exposed to chromate (Fernandes et al.,
1999). In fact, the results of previous studies,
which reported that pretreatment of primary cul-
tures of rat hepatocytes with vitamin E and DFO
protected cells from chromate-induced cytotoxic-
ity and peroxidation (Susa et al., 1996, 1997),
showed that vitamin E normalized the levels of
glutathione and vitamin C suppressed by chro-
mate (Susa et al., 1996), and that DFO attenuated
the suppression of the levels of vitamin E and C
as well as the inhibition of glutathione peroxidase
activity attributed to chromate (Susa et al., 1997).
In summary, pretreatment of human erythro-
cytes with vitamin E, vitamin C, salicylate, and
DFO potentiates chromate-induced cytotoxicity,
while by contrast it is attenuated by NEM. In
turn, chromate-induced peroxidation is prevented
by pretreatment of human erythrocytes with
DFO, while it is potentiated by NEM at least in
the first 4 h of exposition of human erythrocytes
to chromate. Therefore, care must be taken when
using these drugs as antagonist agents for chromi-
um(VI) compounds.
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